HRSA Seeks Input on 340B Program Paperwork
Published Date: 2/26/2026
Notice
Summary
HRSA is planning a new 340B Rebate Model Pilot Program to help drug manufacturers and healthcare providers work together on drug pricing. They want your feedback on the application and reporting process before April 27, 2026. This pilot aims to improve how rebates are handled, making the 340B program fairer and more efficient without extra costs for participants.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Large Reporting Burden for Covered Entities
If you are a 340B covered entity, you may need to submit claims-level data to a third-party platform 52 times per year, with an expected average of 5 hours per submission. HRSA estimates 14,600 covered entities would produce 759,200 responses annually, totaling 3,796,000 annual burden hours.
Manufacturer Plan Submissions and Reports
Qualifying drug manufacturers (limited to manufacturers with Medicare Drug Price Negotiation Program Agreements for the initial price applicability years 2026 and 2027) would submit a single plan (8 hours) and monthly purchase reports (12 reports per year at 2 hours each). HRSA estimates 13 manufacturers, with 13 plan submissions and 156 monthly reports totaling 416 burden hours.
Monthly Data to Improve 340B Oversight
HRSA would require monthly data submissions to the 340B Prime Vendor to evaluate program integrity and increase transparency; monthly reporting is intended to reduce lag time in assessing 340B Program metrics and support ongoing evaluation of the pilot.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22403, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: Faculty Loan Repayment Program, OMB No. 0906-0082-Revision
The Health Resources and Services Administration (HRSA) is updating its Faculty Loan Repayment Program, which helps health pros from tough backgrounds pay off student loans in exchange for teaching at health schools. They’re asking for public feedback by December 3, 2026, before finalizing changes. This update could affect how applicants prove their eligibility and submit loan info, but it won’t change the money or service time required.
2026-21857, Agency Information Collection Activities: Submission to OMB for Review and Approval: Public Comment Request; Organ Procurement and Transplantation Network Board of Directors and Committee Member Applications and Forms
The Health Resources and Services Administration (HRSA) is asking for public feedback on new application forms for the Organ Procurement and Transplantation Network’s Board and committees. These forms help pick the right people to guide organ donation and transplant efforts across the U.S. If you want to share your thoughts, you’ve got until October 27, 2026, and there’s no cost to comment—just your voice!
2026-21672, National Vaccine Injury Compensation Program; List of Petitions Received
The National Vaccine Injury Compensation Program just shared a list of new petitions from people claiming vaccine-related injuries. If you or someone you know got hurt by certain vaccines, this program helps you seek compensation without blame. The Court of Federal Claims reviews these cases, and HRSA manages the process, keeping things fair and timely.
2026-21674, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: Advanced Nursing Education Program Specific Form OMB No. 0906-0089-Revision
HRSA is updating a form used by nursing schools that get grants to train advanced nurses. They’re keeping both full-time and part-time options for nurse midwives and anesthetists to keep things clear and consistent. If you have thoughts, you’ve got until November 23, 2026, to share them—no money changes, just smoother paperwork!
2026-21673, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request: National Practitioner Data Bank for Adverse Information on Physicians and Other Health Care Practitioners-45 CFR Part 60 Regulations and Forms, OMB No. 0906-0081-Revision
HRSA is updating the rules and forms for the National Practitioner Data Bank, which tracks important info about doctors and health care workers. This helps hospitals and licensing boards keep health care safe and trustworthy. If you’re involved in health care reporting or checking, get ready for these changes and share your thoughts by November 23, 2026!
2026-21518, Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Maternal and Child Health Bureau Performance Measures for Discretionary Grant Information System, OMB No. 0915-0298-Revision
HRSA is updating how it collects info for maternal and child health grants by changing some form names and removing two forms that are now covered elsewhere. This affects grant applicants and program managers who report data. Public comments are open until November 20, 2026, before final approval, with no new costs involved.
Previous / Next Documents
Previous: 2026-03830, Records Schedules; Administrative Correction Notice
The National Archives is fixing a small mistake in the Department of the Interior’s records schedule by adding some missing temporary rules. This change affects how certain records are handled and needs public feedback by April 13, 2026. No big money changes here, just making sure the paperwork is right and official.
Next: 2026-03834, Formaldehyde Standard; Extension of the Office of Management and Budget's (OMB) Approval of Information Collection (Paperwork) Requirements
OSHA is asking for public feedback to keep collecting paperwork about formaldehyde safety rules. This affects employers who handle formaldehyde, helping keep workers safe without adding extra hassle. Comments are due by April 27, 2026, and there’s no new cost—just a smooth extension of current rules.